What is Organovo Holdings Forward Dividend Yield %?
As of today (2024-05-26), the Forward Annual Dividend Yield of Organovo Holdings is 0.00%.
As of today (2024-05-26), the Trailing Annual Dividend Yield of Organovo Holdings is 0.00%.
ONVO's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.6 * Ranked among companies with meaningful Forward Dividend Yield % only.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Competitive Comparison of Organovo Holdings's Forward Dividend Yield %
For the Biotechnology subindustry, Organovo Holdings's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Organovo Holdings's Forward Dividend Yield % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Organovo Holdings's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Organovo Holdings's Forward Dividend Yield % falls into.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Organovo Holdings Forward Dividend Yield % Related Terms
Thank you for viewing the detailed overview of Organovo Holdings's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Organovo Holdings (Organovo Holdings) Business Description
Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo's key instrument platform is the NovoGen Bioprinter. The firm's 3-D bioprinting technologies create tissues using living cells and biocompatible hydrogels.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ONVO has been successfully added to your